SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Titan Biotech submits intimation of sub division of equity shares

29 Nov 2025 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Titan Biotech has informed that the Board of Directors, at its meeting held today i.e. Saturday, 29th November, 2025, at 903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi-110034, have considered and approved the following: a) Sub-division/split of equity shares of the Company, such that 1 (One) equity share having face value of Rs 10 each, fully paid-up, be sub-divided into 5 equity shares having face value of Rs 2 each, fully paid-up and consequential alteration(s) to the Memorandum of Association of the Company subject to the approval of the Members of the Company, by way of postal ballot and any regulatory/statutory approvals, as may be required under applicable laws. The Record date for the purpose of sub division/split of equity shares shall be intimated after seeking approval of the Members of the Company. The Board has approved the notice of Postal Ballot to seek necessary approval of the Members. The said Notice of Postal Ballot shall be submitted to the Stock Exchanges in due course in compliance with the provisions of the Listing Regulations. Details with respect to sub-division/ split of shares and alteration Memorandum of Association of the Company in as required to be disclosed under Regulation 30 read with Schedule III of the Listing Regulations and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, as Annexure A and Annexure B respectively. The meeting of Board of Directors commenced at 10:30 AM and concluded at 11:13 AM. The above information will be available on the website of the company i.e., www.titanbiotechltd.com and BSE i.e., www.bseindia.com.

The above information is a part of company’s filings submitted to BSE.

Titan Bio-Tech Share Price

496.15 0.15 (0.03%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×